Repurposing Colchicine to Improve Vascular Function in Hypertension

• Status: Active, not recruiting
• Trial end date: 2023-04-10
• Target enrollment: 0
• Participant gender: Male

Summary

In this project the potential beneficial effect of the drug colchicine on vascular reactivity and blood pressure will be assessed. Colchicine is a commonly used anti-inflammatory medication approved for the treatment of gout, Familial Mediterranean Fever and pericarditis in Denmark. The current project idea is based on accumulating evidence in the literature for a beneficial role of colchicine treatment in the prevention of cardiovascular disease in parallel with novel mechanistic insight from our own research. Recently, colchicine was associated with a lower risk of cardiovascular disease, including reduced myocardial infarctions, strokes and acute coronary syndrome . However, none of these trials have investigated the effect of colchicine on arterial tone or stiffness, changes to which may underlie the reduced risk of cardiovascular disease associated with colchicine. In support of the hypothesis that colchicine will improve vascular reactivity, a study in 1985 by Lagrue et al. found that daily, low-dose colchicine improved arterial stiffness in a small cohort of hypertensive patients. More recently, colchicine was shown to improve arterial stiffness in patients with Familial Mediterranean fever supporting a cardiovascular protective role of colchicine. Finally, colchicine is also proposed to have anti-inflammatory effects in the vascular system.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Copenhagen
• Collaborator: University of Aarhus
• Treatments: Colchicine

Criteria

Inclusion Criteria:

• Diagnosed with essential hypertension

• BMI<30

• blood pressure (sys/dia) ≥120 mmhg and/or ≥80 mmhg while on hypertensive medication OR

• blood pressure (sys/dia) ≥130 mmhg and/or ≥85 mmhg without hypertensive medication

Exclusion Criteria:

• smoking

• excessive alcohol use

• chronic diseases (beside essential hypertension)